European Patent Office

T 1930/14 (Antibody Purification/HOFFMANN-LA ROCHE) du 28.11.2019

Identifiant européen de la jurisprudence
ECLI:EP:BA:2019:T193014.20191128
Date de la décision
28 novembre 2019
Numéro de l'affaire
T 1930/14
Requête en révision de
-
Numéro de la demande
06753791.0
Langue de la procédure
Anglais
Distribution
Non distribuées (D)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
Method for the purification of Antibodies
Nom du demandeur
F. Hoffmann-La Roche AG
Nom de l'opposant
Boehringer Ingelheim Pharma GmbH & Co. KG
MorphoSys AG
GE Healthcare Bio-Sciences AB
Teschner, Sabine
Strawman Limited
Huenges Martin c/o Maiwald Patentanwalts GmbH
Glaxo Group Limited
Chambre
3.3.04
Sommaire
-
Dispositions juridiques pertinentes
European Patent Convention Art 123(2) (2007)European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)European Patent Convention Art 84 (2007)Rules of procedure of the Boards of Appeal Art 12(2) (2007)Rules of procedure of the Boards of Appeal Art 12(4) (2007)Rules of procedure of the Boards of Appeal Art 13 (2007)
Mots-clés
Novelty - main and auxiliary request 1 (no)
Auxiliary requests 2 and 4 to 6 - Admission (no)
Auxiliary request 3 - clarity (no)
Auxiliary request 7 - allowable (yes)
Exergue
-
Affaires citantes
T 0823/23

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the claims of auxiliary request 7 filed as auxiliary request 11 with the statement of grounds of appeal dated 2 December 2014, and a description and drawings to be adapted thereto, as necessary.

3. Respondent IV's request for a different apportionment of costs is rejected.